High activity growth factor mutants

Details for Australian Patent Application No. 2006314713 (hide)

Owner Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH

Inventors Ploger, Frank; Pohl, Jens; Kruse, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2006314713

PCT Pub. Number WO2007/057212

Priority 05025261.8 18.11.05 EP

Filing date 17 November 2006

Wipo publication date 24 May 2007

Acceptance publication date 6 October 2011

International Classifications

C07K 14/51 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/057212 Priority application(s): WO2007/057212

6 October 2011 Application Accepted

  Published as AU-B-2006314713

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006314714-A readout chip for single photon counting

2006314712-Absorbent articles comprising acidic superabsorber and an organic zinc salt